As we approach the DSCSA’s final implementation deadline (November 27th, 2023), pharmaceutical companies are expected to include unit level serial numbers into the transaction information of prescription drugs and be able to exchange the data electronically. Learn more about what this means by downloading our guideline.
In this DSCSA 2023 Guideline you will learn about:
- 2023 enhanced drug distribution security
- How DSCSA enhanced system requirements can be met
- What information needs to be exchanged
- How product data is provided, captured, and maintained
- How to choose the right aggregation and L4 supplier
* Although the law comes into effect as of November 2023, violations will only be sanctioned as of November, 2024.
